-
Mashup Score: 0
PDF | Introduction: HLA-Haploidentical bone marrow transplant (haplo-BMT) is a curative approach for individuals with severe sickle cell disease (SCD)… | Find, read and cite all the research you need on ResearchGate
Source: ResearchGateCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0
We describe outcomes with posttransplantation cyclophosphamide and non-myeloablative conditioning based allogeneic blood or marrow transplantation for…
Source: www.sciencedirect.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1Haploidentical Stem Cell Transplantation With Posttransplant Cyclophosphamide for Pediatric Acute Leukemia is Safe and Effective | Request PDF - 2 year(s) ago
Request PDF | Haploidentical Stem Cell Transplantation With Posttransplant Cyclophosphamide for Pediatric Acute Leukemia is Safe and Effective | Background: Haploidentical family donor is universally available and is fast emerging as an alternative donor choice for children with leukemia… | Find, read and cite all the research you need on ResearchGate
Source: ResearchGateCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1
The introduction of post-transplantation cyclophosphamide (PTCy) as graft-versus-host disease (GVHD) prophylaxis has made haploidentical (haplo) hemat…
Source: www.sciencedirect.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Paper: Phase I/II Study of Reduced Dosing of Post-Transplantation Cyclophosphamide (PTCy) after HLA-Haploidentical Bone Marrow Transplantation - 2 year(s) ago
Oral and Poster Abstracts Oral 722. Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Prevention of graft vs. host disease after allogeneic hematopoietic cell transplantation Clinical Trials, Adults, Biological, GVHD, Clinical Research, Clinically Relevant, Immune Disorders, Diseases, Therapies, Study Population,…
Source: ash.confex.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0(PDF) Upfront Haploidentical Stem Cell Transplant With Posttransplant Cyclophosphamide in Children With Severe Aplastic Anemia - 2 year(s) ago
PDF | In children with severe acquired aplastic anemia, although matched sibling donor (MSD) hematopoietic stem cell transplant (HSCT) is standard of… | Find, read and cite all the research you need on ResearchGate
Source: ResearchGateCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 3Case Report: Haploidentical Bone Marrow Transplantation in Two Brothers With Wiskott–Aldrich Syndrome Using Their Father as the Donor - 3 year(s) ago
Wiskott–Aldrich syndrome (WAS) is an X-linked genetic disorder with a variable phenotypic expression that includes thrombocytopenia, eczema, and immunodeficiency. Some patients may also exhibit autoimmune manifestations. Patients with WAS are at increased risk of developing malignancies such as lymphoma. Allogeneic hematopoietic cell transplantation remains the only curative treatment….
Source: FrontiersCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 2
Request PDF | Successful Haploidentical Stem Cell Transplant With Posttransplant Cyclophosphamide for Isolated Central Nervous System Blast Crisis in a Child With Chronic Myeloid Leukemia | Chronic myelogenous leukemia (CML) is a myeloproliferative disorder. The extramedullary blast crisis (BC) is a known complication of CML, but it… | Find, read and cite all the research you need on…
Source: ResearchGateCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0PTCy associated with increased CMV infection - 3 year(s) ago
Goldsmith SR, Abid MB, Auletta JJ, et al. Posttransplant Cyclophosphamide Is Associated With Increased Cytomegalovirus Infection: A CIBMTR Analysis. Blood. 2021; 137 (23) (doi: 10.1182/blood.2020009362). An analysis of patients reported to the Center for International Blood and Marrow Transplantation Research between 2012 and 2017 found that post-transplant cyclophosphamide (PTCy) elevated the…
Source: ASTCT NucleusCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 5
: The prognosis of acute leukemia refractory to induction chemotherapy or immunotherapy is dismal. Salvage allogeneic hematopoietic stem cell transplantation (HSCT) is widely used option for these patients, but only 10-15% of patients are cured by the procedure. Preclinical studies indicate that substitution of posttransplantation cyclophosphomide (PTCY) with bendamustine (PTB) in a prophylaxis…
Categories: Hem/Oncs, Latest HeadlinesTweet
Outcomes of Non-Myeloablative HLA-Haplo BMT with Thiotepa & PTCy in Children & Adults with Severe Sickle Cell Disease Phase II Trial: Vanderbilt Global Haploidentical Transplant Learning Collaborative @josudelafuente #VGC2 #Haplo #PTCy #Sickle https://t.co/njp0hyJKgT